Clamart, France, September 16, 2024 – Sixty years ago, our company embarked on a mission to transform medical technology with the implantation of our first product. This device, the “SCI-4” pacemaker, where “SCI” stands for “Stimulateur Cardiaque Intracorporel” in French, meaning “Intracorporal Pacemaker”, was implanted in Europe, in a patient during the summer of 1964.
Benoît Clinchamps, President of MicroPort® CRM, says: “I am very proud of the long history of the company, and our capacity to innovate over 60 years. To date, millions of MicroPort® CRM devices have improved the lives of patients worldwide. As part of our ongoing commitment to advancing patient care and supporting healthcare professionals, we will continue to drive innovation and expand our technology across the globe."
Transforming Lives Worldwide
Over the past six decades, our initial product has undergone numerous enhancements, adapting to changing medical practices and incorporating cutting-edge technologies. Each iteration has aimed to provide better performance, increased reliability, longevity and greater patient comfort. Today, our product continues to save lives and enhance the quality of life for millions of people around the globe.
Innovation and Collaboration with HealthCare Professionals at the Core
From the very beginning, innovation and collaboration with Healthcare Professionals have been at the heart of our operations. The first implantation was more than a technical achievement; it was a symbol of our commitment to improving patient outcomes and advancing medical practices.
Alain Ripart, Founder of ELA Medical and retired Chief Scientific Officer at Sorin Group/ MicroPort® CRM, a pioneer in cardiac pacing, recently said: “One of our strengths has been our very close collaboration with Healthcare Professionals. Developing a product with doctors nearby allowed for constant interaction, which was essential in advancing our technology.”
A Legacy of Excellence
The journey from our first product to our current portfolio is a testament to our unwavering dedication to innovation and quality. Our team of scientists, engineers, and healthcare professionals has consistently pushed the boundaries of what is possible, ensuring that our products meet the highest standards of safety and efficacy.
Looking to the Future
As we celebrate this significant anniversary, we are also looking to the future. The lessons learned and the experiences gained over the past 60 years will guide us as we continue to explore new frontiers in medical technology. Our commitment to innovation remains as strong as ever, with ongoing research and development focused on creating solutions that address the evolving needs of patients and healthcare providers.
Gratitude and Commitment
We extend our deepest gratitude to our dedicated employees, and the medical community for their unwavering support and collaboration. Their contributions have been instrumental in achieving this milestone.
The 60th anniversary of the first implantation of our inaugural product is not only a tribute to our history but also a guiding light for our future. As we honor this remarkable achievement, we remain committed to our mission of enhancing health and well-being through innovative medical solutions. Here’s to the next 60 years of breakthroughs, advancements, and making a difference in the lives of people worldwide.
Thank you for being a part of our journey!
About MicroPort CRM
MicroPort® CRM is a pioneering company in the field of Cardiac Rhythm Management (CRM), and a subsidiary of MicroPort Scientific Corporation (stock code: 00853.HK), with world headquarters in Clamart, near Paris, France. Through our long-standing expertise in CRM, MicroPort® CRM develops, manufactures and markets around the world cardiac pacemakers, implantable cardiac defibrillators, cardiac resynchronization systems and ECG diagnostic solutions for the management of cardiac rhythm disorders and heart failure. Our state-of-the-art products are manufactured in Clamart, France, Saluggia, Italy, and in Santo Domingo, Dominican Republic.
For more information, please refer to www.microport.com